Andres E Mendez-Hernandez, MD
Hematology/Oncology · Aberdeen
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Avera Mckennan · 957 clinicians in this group
Looking this up.
Hospitals listed: Avera Mckennan Hospital & University Health Center · Avera Missouri River Health Center · Avera Queen of Peace · Avera St Lukes · Avera St Mary'S Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mendez-Hernandez’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A188614 · Delinquent
Licence status: Delinquent · since 2023 · expires 2025-10-30 · University of Zulia School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125068361Temporary Medical Permit · since 2016 · expires 2019-06-30Specialty on the licence: Internal MedicineCancelledNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Avera Mckennan Hospital & University Health CenterSioux Falls, SDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Avera Health, which runs 42 hospitals in 4 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.226, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.318, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.374, Oct 2024 – Sep 2025
- Avera Missouri River Health CenterGettysburg, SDCritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Avera Health, which runs 42 hospitals in 4 statesNo overall ratingNo measure marked better or worse than the national rate
- Avera Queen of PeaceMitchell, SDCritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Avera Health, which runs 42 hospitals in 4 statesPatients rate it 4 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Avera St LukesAberdeen, SDAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Avera Health, which runs 42 hospitals in 4 statesPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Avera St Mary'S HospitalPierre, SDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Avera Health, which runs 42 hospitals in 4 statesPatients rate it 4 of 5 · 64% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Avera Mckennan Hospital & University Health Center
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.226 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.318 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.35 to 1.91) · 2,910 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.79 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 170.45 (130.76 to 210.13) · 158 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 167 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.4 · 332 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 560 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 535 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,735 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.33) · 10,545 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.06 to 0.42) · 10,666 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (1.75 to 4.94) · 3,245 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.47) · 1,698 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.21 (0.97 to 3.44) · 3,115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8 (3.01 to 12.99) · 1,683 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.26 (2.49 to 8.04) · 1,581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.34 to 3.1) · 954 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.04 (0.54 to 1.54) · 8,718 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 174 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.777 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.658 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.525 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 398 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.1 · 365 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.3 · 654 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 739 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4.2 to 7.2) · 544 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.5 (7.7 to 11.8) · 544 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 148 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.1 · 251 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.5 (11.9 to 17.7) · 4,024 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 2,535 cases | No different | Jan 2024 – Dec 2024 |
What patients said (711 patients answered, 28% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Avera Missouri River Health Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 16.5 · 29 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 43 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 32.3 · 29 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 25 cases | None | Jul 2023 – Jun 2025 |
See every measure and the patient survey for Avera Queen of Peace
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 9.1 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.1 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.4 · 25 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 458 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 50 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 73 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 40.6 · 66 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -20.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 130 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (7.4 to 14.3) · 130 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.3 to 16.9) · 323 cases | No different | Jan 2022 – Dec 2024 |
What patients said (325 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Avera St Lukes
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.07) · 478 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.66 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 172.14 (113 to 231.28) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 66 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 835 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.02 to 0.47) · 2,382 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.37 (0.16 to 0.58) · 2,366 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.86 (0.63 to 5.09) · 797 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.58 (0 to 3.26) · 353 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.91 (1.29 to 4.53) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0 to 14.43) · 353 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.78 (1.88 to 9.68) · 324 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.05 (0.11 to 2) · 1,814 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 146 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.104 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 89 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 176 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 25.2 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -25.1 · 166 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.8) · 69 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.5 (7.9 to 16.7) · 69 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.2 · 136 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 52 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 648 cases | No different | Jan 2024 – Dec 2024 |
What patients said (547 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 90% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Avera St Mary'S Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 1 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 8 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.1) · 121 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.6 to 1.54) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 14.8 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.7 · 104 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.2 · 28 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 280 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,030 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 997 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.66) · 247 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.38) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.99) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.41 (1.58 to 21.23) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.77 (3.5 to 12.03) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1.6) · 761 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.3 · 63 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 31 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20 · 44 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -18.6 · 97 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 77 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.9 to 6.6) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.6 to 14) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10.2 to 17.4) · 934 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 393 cases | No different | Jan 2024 – Dec 2024 |
What patients said (263 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$15,900
Medicare paid this office $15,900 for 79 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 45 | $6,102 | $136 |
| Return visit (30+ min) | 12 | $1,683 | $73 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $960 | $37 |
Who their Medicare patients are
79 Original Medicare patients in 2024. Average age 74 · Women 38% · Health risk score 1.56. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 75% · Diabetes 32% · Coronary heart disease 32% · Chronic kidney disease 32% · Atrial fibrillation 27% · Depression 27% · Heart failure 19% · COPD 19% · Cancer 18%.
The office billed $25,421, Medicare allowed $20,034 and paid $15,900; for 183 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$57,076
Pharmacies billed $57,076 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
118 generic and fewer than 11 brand-name prescriptions · $57,076 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Acyclovir | 11 | $764 | $20 |
Year by year
| 2024 | 130 | 30 | None | None | $57,076 |
| 2023 | 102 | 23 | None | 15% | $262,640 |
| 2022 | 74 | 22 | None | None | $157,464 |
| 2021 | 131 | 38 | 14% (18) | 23% | $159,499 |
| 2020 | 60 | 30 | None | None | $1,661 |
| 2019 | 132 | 19 | 0% (0) | None | $1,566 |
| 2018 | 21 | None | 0% (0) | None | $726 |
| 2017 | 45 | 12 | 0% (0) | None | $786 |
| 2016 | 18 | None | 0% (0) | None | $1,782 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Hydroxyurea | 11 | $563 | $51 |
2021: 1 drug
| Gabapentin | 11 | $89 | $8 |
2019: 2 drugs
| Atorvastatin | 24 | $299 | $12 |
| Metformin | 12 | $50 | $4 |
Money from drug and device companies
$685 in 2025
| 2025 | 14 | 17 | None | $685 |
| 2024 | 11 | 12 | None | $368 |
| 2021 | 2 | 2 | None | $175 |
| 2020 | 1 | 1 | None | $122 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Kite Pharma | Yescarta | $151 | 2 payments
|
| Daiichi Sankyo | Vanflyta | $123 | 1 payment
|
| Geron | Rytelo | $106 | 1 payment
|
| Celgene | Reblozyl | $76 | 2 payments
|
| Regeneron Healthcare Solutions | Lynozyfic | $38 | 1 payment
|
| Genzyme | Sarclisa | $38 | 2 payments
|
See all 17 published payments
| Genzyme | Meals · 2025-09-17 | Wayrilz | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-08-20 | Lynozyfic | $38 |
| Daiichi Sankyo | Meals · 2025-07-29 | Vanflyta | $123 |
| Adc Therapeutics America | Meals · 2025-05-21 | Zynlonta | $16 |
| Syndax Pharmaceuticals | Meals · 2025-04-23 | None | $20 |
| Genentech USA | Meals · 2025-04-15 | Venclexta | $22 |
| Genzyme | Meals · 2025-03-28 | Sarclisa | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-26 | Calquence | $19 |
| Janssen Biotech | Meals · 2025-03-19 | Tecvayli | $24 |
| Teleflex | Meals · 2025-03-19 | Arrow | $14 |
| Geron | Meals · 2025-03-18 | Rytelo | $106 |
| Kite Pharma | Meals · 2025-02-26 | Yescarta | $34 |
| Celgene | Meals · 2025-02-20 | Reblozyl | $44 |
| Kite Pharma | Meals · 2025-02-11 | None | $118 |
| Legend Biotech USA | Meals · 2025-01-31 | Carvykti | $23 |
| Alexion Pharmaceuticals | Meals · 2025-01-30 | Ultomiris | $15 |
| Celgene | Meals · 2025-01-24 | Breyanzi | $32 |
See earlier years (2024, 2021, 2020)
2024: $368
| ADC Therapeutics America | None | $144 | 2 payments
|
| Celgene | None | $40 | 1 payment
|
| Legend Biotech USA | None | $29 | 1 payment
|
| Mallinckrodt Hospital Products | Cellex | $25 | 1 payment
|
| BeiGene USA | Brukinsa | $23 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $21 | 1 payment
|
| Abbvie | Imbruvica | $21 | 1 payment
|
| PharmaEssentia USA | Besremi | $19 | 1 payment
|
| Genentech USA | Venclexta | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Calquence | $15 | 1 payment
|
| Janssen Biotech | Carvykti | $13 | 1 payment
|
2021: $175
| Stemline Therapeutics | None | $101 | 1 payment
|
| Incyte | Monjuvi | $74 | 1 payment
|
2020: $122
| Incyte | Monjuvi | $122 | 1 payment
|
Professional record
- NPI
- 1487006813
- Licence
- CA A188614, IL 125068361, NM RS2020-0510California A188614: Delinquent · expires 2025-10-30Illinois 125068361: Cancelled
- Group
- Avera Mckennan
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr Rm H0101, Stanford, CA, 94305
- NPI first listed
- 2016-07-11
- NPI last updated
- 2023-08-11
- NPI record certified
- 2023-07-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: Msc (Internal M) 1 University of New Mexico Albuquerque, Albuquerque, NM, 87131 · 1901 W Harrison St, Chicago, IL, 60612